Zobrazeno 1 - 10
of 18
pro vyhledávání: '"S. D. Bezhanova"'
Autor:
V. O. Varachev, O. Yu. Susova, A. A. Mitrofanov, G. S. Krasnov, D. R. Naskhletashvili, Yu. I. Ammour, S. D. Bezhanova, N. V. Sevyan, E. V. Prozorenko, A. Kh. Bekyashev, T. V. Nasedkina
Publikováno v:
Успехи молекулярной онкологии, Vol 11, Iss 3, Pp 68-78 (2024)
Introduction. Epidermal growth factor receptor (EGFR) is a transmembrane protein of the receptor tyrosine kinase family that is activated in various cancers (non-small cell lung cancer, colorectal cancer, head and neck tumors). In glial brain tumors,
Externí odkaz:
https://doaj.org/article/c74688be09cf44c580704332ebb593c1
Autor:
N. E. Kushlinskii, E. S. Gershtein, A. V. Kolpakov, S. D. Bezhanova, V. V. Mushtenko, E. A. Korotkova, D. Yu. Pushkar, V. V. Bazaev
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 48, Iss 2, Pp 78-83 (2020)
Background: Evaluation and search for new molecular markers of renal cell cancer, first of all, associated with angiogenic and invasive activity, continue to be highly relevant. In our previous publications, we have assessed the potential diagnostic
Externí odkaz:
https://doaj.org/article/6883655858c94f419fd49649dcb38a4b
Publikováno v:
Опухоли головы и шеи, Vol 8, Iss 2, Pp 83-87 (2018)
Oropharyngeal metastases are very rare and occur in approximately 1.0–1.5 % of all malignant tumors of the oral cavity and oropharynx. Information on oropharyngeal localization of metastases of kidney cancer is almost absent in the literature. A de
Externí odkaz:
https://doaj.org/article/33a9fb69f1ef461696cf06f2e4b99536
Autor:
E. S. Gershtein, V. V. Mushtenko, E. A. Korotkova, S. D. Bezhanova, A. A. Morozov, A. A. Alferov, I. A. Kazantseva, N. E. Kushlinskii
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 45, Iss 2, Pp 94-101 (2017)
Background: The cause of late diagnosis of renal cancer lies in its durable, almost asymptomatic course. Due to the use of antiangiogenic therapies much progress has been made in its treatment in recent years. Yet, many questions concerning the diagn
Externí odkaz:
https://doaj.org/article/ed22f022192e4f83ae677c19cde0a701
Autor:
O. V. Kovaleva, A. N. Gratchev, E. I. Makarova, S. D. Bezhanova, I. S. Stilidi, V. B. Matveev, N. E. Kushlinskii
Publikováno v:
Cancer Urology. 18:17-28
Background. The search for new prognostic markers of renal cell carcinoma is an urgent problem of oncourology. Modern studies demonstrate the need for a comprehensive assessment of the clinical and prognostic significance of many markers.Aim is a com
Publikováno v:
Опухоли головы и шеи, Vol 6, Iss 3, Pp 67-70 (2016)
We present rare clinical case of laryngeal paraganglioma. Modern possibilities of the disease diagnostics, determination of the prevalence of tumor process, methods, and assessment of the effectiveness of treatment are shown in this paper.
Externí odkaz:
https://doaj.org/article/64f66e5200964c409eae5860f2292bfe
Autor:
E. S. Gershtein, D Yu Pushkar, V. V. Mushtenko, S D Bezhanova, A. V. Kolpakov, N. E. Kushlinskii, E A Korotkova, V. V. Bazaev
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 48, Iss 2, Pp 78-83 (2020)
Background: Evaluation and search for new molecular markers of renal cell cancer, first of all, associated with angiogenic and invasive activity, continue to be highly relevant. In our previous publications, we have assessed the potential diagnostic
Autor:
V. V. Mushtenko, E. S. Gershtein, D Yu Pushkar, Vsevolod Matveev, S D Bezhanova, Ivan Stilidi, N. E. Kushlinskii, A A Alferov
Publikováno v:
Bulletin of Experimental Biology and Medicine. 168:673-676
The study compared the levels of MMP-2,7,8,9, and TIMP-1 in blood serum of healthy people (N=97) and patients with primary renal cell carcinoma (N=93) to assess relevance of these markers to prognosis of overall survival of these patients, which were
Autor:
N. E. Kushlinskii, E. S. Gershtein, I. O. Goryatcheva, A. A. Morozov, A. A. Alferov, S. D. Bezhanova, I. A. Kazantseva, V. V. Bazaev, V. B. Matveev
Publikováno v:
Onkourologiâ, Vol 15, Iss 1, Pp 15-22 (2019)
Background. Renal cancer is one of the most immunosensitive oncologic diseases. A prominent breakthrough in this field was gained with the development of medications directed to the suppression of PD-1/PD-L immune check-point signaling pathway that i
Autor:
D. G. Zaridze, N. N. Mazurenko, S. D. Bezhanova, D. M. Maksimovich, O. V. Shangina, V. A. Draudin-Krylenko, A. F. Mukeria, V. B. Matveev
Publikováno v:
Onkourologiâ, Vol 15, Iss 1, Pp 23-31 (2019)
Background . Clear-cell renal-cell carcinoma (CCRCC) is the most common histological type of cancer of this localization. Changes in 16 genes were identified as significant in carcinogenesis of CCRCC. After VHL suppressor gene, PBRM1 gene is the seco